Indecainide
Indecainide[edit | edit source]
Indecainide is a pharmaceutical compound that was developed as an antiarrhythmic agent. It belongs to the class of drugs known as Class I antiarrhythmic agents, which work by blocking sodium channels in the heart, thereby affecting the cardiac action potential and stabilizing the cardiac rhythm.
Mechanism of Action[edit | edit source]
Indecainide functions primarily by inhibiting the fast sodium channels in the cardiac myocytes. This action results in a decrease in the rate of depolarization during phase 0 of the cardiac action potential. By slowing down the conduction velocity, Indecainide can help to correct abnormal heart rhythms, such as ventricular tachycardia and atrial fibrillation.
Pharmacokinetics[edit | edit source]
Indecainide is administered orally and is absorbed through the gastrointestinal tract. It undergoes hepatic metabolism and is excreted primarily through the kidneys. The drug has a relatively short half-life, which necessitates frequent dosing to maintain therapeutic levels in the bloodstream.
Clinical Use[edit | edit source]
Indecainide was primarily used in the treatment of life-threatening ventricular arrhythmias. However, due to the development of newer antiarrhythmic agents with better safety profiles, its use has declined. It is important to monitor patients for potential side effects, including proarrhythmic effects, which can exacerbate existing arrhythmias or create new ones.
Side Effects[edit | edit source]
Common side effects of Indecainide include dizziness, nausea, and headache. More serious side effects can include proarrhythmia, hypotension, and heart failure. Due to these potential adverse effects, careful monitoring of patients is required during treatment.
History[edit | edit source]
Indecainide was developed in the late 20th century as part of a broader effort to find effective treatments for cardiac arrhythmias. While it showed promise in early trials, its use was eventually overshadowed by other medications with improved efficacy and safety profiles.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
